The effects of vitamin D deficiency on atrial fibrillation

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 1, 2014, Pages 98-103

  Demir, Mehmet ^a   Uyan, Umut ^a   Melek, Mehmet ^a  

^a BURSA YUKSEK IHTISAS TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

arrhythmia; atrial fibrillation; renin angiotensin aldosterone system; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANTIHYPERTENSIVE AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; PARATHYROID HORMONE;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SINUS RHYTHM; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; VITAMIN D DEFICIENCY;

ARRHYTHMIA; ATRIAL FIBRILLATION; RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM; VITAMIN D;

AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84890466201     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612453762     Document Type: Article

References (40)

1. Falk RH. Atrial Fibrillation. N Engl J Med. 2001 ; 344 (14). 1067-1078
2. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines fort he management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006 ; 48 (4). 854-906
3. Go AS, Hylek EM, Philips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA. 2001 ; 285 (18). 2370-2375
4. Shah M, Akar FG, Tomaselli GF. Molecular basis of arrhytmias. Circulation. 2005 ; 112 (16). 2517-2529
5. Gassanov N, Brandt MC, Michels G, Lindner M, Er F, Hoppe UC. Angiotensin II induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodelling in atrial fibrillation. Cell Calcium. 2006 ; 39 (2). 175-186
6. Cardus A, Parisi E, Gallego C, Aldea M, Fernández E. Valdivielso JM. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int. 2006 ; 69 (8). 1377-1384
7. Kannel WB, Wolf PA, Benjamin EJ, Levy D.. Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998 ; 82 (8A). 2N - 9N
8. Lang RM, Bierig M, Devereux RB, et al. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Task Force on Chamber Quantification: recommendations for chamber quantification. Eur J Echocardiogr. 2006 ; 7 (2). 79-108
9. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004 ; 80 (6 suppl). 1689-1996
10. Pepys MB, Hirschfield GM, Tennent GA, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature. 2006 ; 440 (7088). 1217-1221
11. Keaney JF. Oxidative stress and the vascular wall: NADPH oxidates take center stage. Circulation. 2005 ; 112 (17). 2585-2588
12. Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol. 2000 ; 35 (6). 1669-1677
13. Milliez P, Giererd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldesteronism. J Am Coll Cardiol. 2005 ; 45 (8). 1243-1248
14. Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S. Evolution of atrial fibrillation substrate in experimental congestive heart failure: angiotensin dependent and independent pathways. Cardiovasc Res. 2003 ; 60 (2). 315-325
15. Anand K, Mooss AN, Hee TT, Mohiuddin SM. Meta-analysis: inhibition of renin angiotensin system prevents new-onset atrial fibrillation. Am Heart J. 2006 ; 152 (2). 217-222
16. Kalus JS, Coleman CI, White CM. The impact of supressing the renin-angiotensin system on atrial fibrillation. J Clin Pharmacol. 2006 ; 46 (1). 21-28
17. Hollick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancer and cardiovascular disease. Am J Clin Nutr. 2004 ; 80 (6 suppl). S1678 - S1688
18. Holick MF. Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J. 2005 ; 98 (10). 1024-1027
19. DeLuca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J. 2001 ; 15 (14). 2579-2585
20. Mathieu C, Van Etten E, Decallonne B, et al. Vitamin D and 1,25 dihydroxyvitamin D3 as modulators in immune system. J Steroid Biochem Mol Biol. 2004 ; 89-90 (1-5). 449-452
21. Mathieu C, Adorini L. The coming age of 1,25 dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med. 2002 ; 8 (4). 174-179
22. Sooy K, Schermerhorn T, Noda M, et al. Calbindin-D(28k) control (Ca+132)(i) and insülin release. Evidence obtained from calbindin-d(28k) knockout mice beta cell lines. J Biol Chem. 1999 ; 274 (48). 34343-34349
23. Gregory S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1 alpha, 25 dihydroxyvitamin D(3) anolog enhances regulatory T-cell and arrest autoimmune diabetes in NOD mice. Diabetes. 2002 ; 51 (5). 1367-1374
24. Mathiue C, Waer M, Laurey J, Rutgeers O, Bouillion R. Prevention of autoimmundiabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia. 1994 ; 37: 552-558
25. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001 ; 358 (9292). 1500-1503
26. Holic MF. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008 ; 3 (5). 1548-1554
27. Norval M. The effect of ultraviolet radiation on human viral infections. Photochem Photobiol. 2006 ; 82 (6). 1495-1504
28. Najada AS, Habashneh MS, Khader M. The frequency of nutritional rickets among hospitalized infants and its relation to respiratory diseases. J Trop Pediatr. 2004 ; 50 (6). 364-368
29. Manolagas SC, Werntz DA, Tsoukas CD, Proveddini DM. Vaughan JH. 1,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis. J Lab Clin Med. 1986 ; 108 (6). 595-600
30. Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol. 2006 ; 92 (1). 60-64
31. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saaq KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the lowa Women's Health Study. Arthritis Rheum. 2004 ; 50 (1). 72-77
32. Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E. A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev. 2008 ; 29 (2). 133-154
33. Courbebaisse M, Souberbielle JC, Thervet E. Potential nonclassical effects of vitamin D in transplant recipients. Transplantation. 2010 ; 89 (2). 131-137
34. Resnick LM, Muller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med. 1986 ; 105 (5). 649-654
35. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997 ; 96 (4). 1180-1184
36. Nakamura Y, Nakamura K, Fukushima-Kusano K, et al. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res. 2003 ; 111: 137-142
37. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001 ; 104 (24). 2886-2891
38. Siu CW, Lau CP, Tse HF. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol. 2003 ; 92 (11). 1343-1345
39. Rostand SG, Drüeke TB. Prathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. KIdney Int. 1999 ; 56 (2). 383-392
40. Rienstra M, Cheng S, Larson MG, et al. Vitamin D status is not related to development of atrial fibrillation in the community. Am Heart J. 2011 ; 162 (3). 538-541